Dark

BEAT
Heartbeam, Inc. Common Stock
stock NASDAQ

At Close

Jul 31, 2026 3:25:25 PM EDT

0.5000USD-3.077%(-0.0200)361,346

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Jul 31, 2026 9:18:30 AM EDT

0.5171USD-0.558%(-0.0029)3,654

After-hours

Jul 31, 2026 4:35:30 PM EDT

0.5024USD-0.317%(-0.0016)12,166

Overview HistoricalExchangesShortsNews

Jan 27, 2022

09:53AM EST HeartBeam Appoints Michael Gibson As Chairman RTTNews

09:42AM EST HeartBeam Establishes Scientific Advisory Board and Appoints C. Michael Gibson, MD as Chairman Business Wire

Jan 4, 2022

10:51AM EST Heartbeam Receives Decision To Grant European Patent Titled 'MOBILE THREE-LEAD CARDIAC MONITORING DEVICE' Benzinga

Dec 29, 2021

08:31AM EST HeartBeam to Participate in the H.C. Wainwright BIOCONNECT Conference Business Wire

Dec 22, 2021

08:38AM EST HeartBeam, Inc. (BEAT) has appointed Alan Baumel as Chief Operating Officer. Baumel will lead product development, manufacturing, quality assurance, and regulatory affairs as Chief Operating Officer, which is a new role at HeartBeam. Before joining HeartBeam, Baumel was Program Director of the Case for Quality Collaborative Community at Medical Device Innovation Consortium. RTTNews

08:34AM EST HeartBeam Appoints Alan Baumel As Chief Operating Officer Benzinga

08:33AM EST HeartBeam Appoints Alan Baumel As COO RTTNews

08:31AM EST HeartBeam Appoints Alan Baumel as Chief Operating Officer Business Wire

Dec 20, 2021

11:58AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2021 Benzinga

07:21AM EST Benchmark Initiates Coverage On BioTelemetry with Speculative Buy Rating, Announces Price Target of $9 Benzinga

Dec 16, 2021

04:03PM EST HeartBeam Reports Q3 2021 EPS $(0.32) Benzinga

04:01PM EST HeartBeam Reports Third Quarter and Nine Months 2021 Financial Results Business Wire

Nov 17, 2021

08:31AM EST HeartBeam Announces Closing of Initial Public Offering Business Wire

07:58AM EST Sabby Management, LLC Discloses 5.16% Passive Stake In HeartBeam Benzinga

Nov 11, 2021

10:43AM EST Heartbeam Shares Open For Trade At $5.40; IPO Priced $6/Share Benzinga

10:18AM EST Heartbeam Shares Indicated $5.74 Benzinga

09:20AM EST Heartbeam Shares Will Open For Quote At 10:10 a.m. EST, Expected To Open For Trade After 10:20 a.m. EST; IPO Priced $6/Share Benzinga

Nov 10, 2021

10:18PM EST HeartBeam Prices IPO Of 2.75 Mln Units At $6.00/unit RTTNews

10:10PM EST HeartBeam Announces Pricing of $16.5 Million Initial Public Offering Business Wire

Mar 25, 2021

09:56AM EDT Philips Divests Appliances Business To Hillhouse For $4.4B: Bloomberg Benzinga

Feb 2, 2021

07:40PM EST Investors Bancorp To Replace BioTelemetry In S&P SmallCap 600 RTTNews

06:51PM EST Investors Bancorp Set to Join S&P SmallCap 600 PR Newswire

Jan 7, 2021

01:55PM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: GlobeNewswire Inc

10:10AM EST Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: GlobeNewswire Inc

Jan 5, 2021

11:28AM EST ALERT: Halper Sadeh LLP Investigates TDY, TCP, BEAT, HCAP, SNSS; Shareholders PR Newswire

10:50AM EST Moore Kuehn Encourages BEAT, MGLN, RLH, and ELY Investors to Contact Law Firm PR Newswire

Dec 30, 2020

10:31AM EST P/E Ratio Insights for BioTelemetry Benzinga

10:04AM EST Benzinga's Top Upgrades, Downgrades For December 30, 2020 Benzinga

07:41AM EST Truist Securities Downgrades BioTelemetry to Hold Benzinga

Dec 28, 2020

08:15PM EST SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - PS, PR Newswire

Dec 27, 2020

11:50PM EST CORRECTING and REPLACING BIOTELEMETRY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioTelemetry, Inc. - BEAT Business Wire

Dec 24, 2020

11:49PM EST Lifshitz Law Firm, P.C. Announces Investigation of ANCN, BEAT, HMSY, SNCA, PR Newswire

Dec 22, 2020

08:00AM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: GlobeNewswire Inc

Dec 21, 2020

11:00AM EST Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: GlobeNewswire Inc

Dec 19, 2020

04:11PM EST SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following PR Newswire

Dec 18, 2020

10:00PM EST SHAREHOLDER ALERT: WeissLaw LLP Investigates BioTelemetry, Inc. PR Newswire

07:07PM EST Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of BioTelemetry, Inc. (NASDAQ: BEAT)breached their fiduciary duties in connection with the proposed sale of the Company to Royal Philips (NYSE: PHG, AEX: PHIA). GlobeNewswire Inc

03:30PM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of BioTelemetry, Inc. (NASDAQ: BEAT) breached their fiduciary duties or violated the federal securities laws in connection with the companys acquisition by Koninklijke Philips N.V. (NYSE: PHG) (Royal Philips). GlobeNewswire Inc

02:18PM EST ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of BioTelemetry, PR Newswire

10:22AM EST ROCE Insights For BioTelemetry Benzinga

10:10AM EST Benzinga's Top Upgrades, Downgrades For December 18, 2020 Benzinga

10:09AM EST Rigrodsky & Long, P.A. announces that it is investigating BioTelemetry, Inc. (BioTelemetry) (NASDAQ GS: BEAT) regarding possible breaches of fiduciary duties and other violations of law related to BioTelemetrys agreement to be acquired by Royal Philips. Under the terms of the agreement, BioTelemetrys shareholders will receive $72.00 in cash per share. GlobeNewswire Inc

10:03AM EST Shares of remote medical technology company BioTelemetry, Inc. (BEAT) are surging more than 17% Friday morning after Royal Philips (PHG) has agreed to buy the company for about $2.8 billion. RTTNews

09:28AM EST Needham Downgrades BioTelemetry to Hold, Announces $52 Price Target Benzinga

09:03AM EST BioTelemetry Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of BioTelemetry, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - BEAT Business Wire

08:52AM EST (BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 PR Newswire

07:48AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data Benzinga

07:45AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data Benzinga

07:26AM EST BioTelemetry Shares Rise 18% After Phillips Agrees to Acquire Co for $72/Share in Cash Benzinga

02:51AM EST Philips to Acquire BioTelemetry GlobeNewswire Inc

02:50AM EST Dutch consumer electronics giant Philips Electronics NV (PHGFF.PK, PHG) announced Friday its agreement to acquire BioTelemetry, Inc. (BEAT), a U.S.-based provider of remote cardiac diagnostics and monitoring, for $72.00 per share, to be paid in cash upon completion. RTTNews

02:33AM EST Philips To Acquire BioTelemetry For $72/Shr; Implied Enterprise Value Of $2.8 Bln RTTNews

Dec 16, 2020

07:15AM EST The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal Benzinga

Dec 11, 2020

08:11AM EST The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga

Dec 2, 2020

07:35AM EST The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod Benzinga

Dec 1, 2020

08:08AM EST The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit Benzinga

Oct 29, 2020

04:31PM EDT BioTelemetry Q3 EPS $0.45 Beats $0.38 Estimate, Sales $114.70M Beat $105.10M Estimate Benzinga

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

04:08AM EDT Earnings Scheduled For October 29, 2020 Benzinga

Oct 28, 2020

10:14AM EDT BioTelemetry's Earnings: A Preview Benzinga

Oct 22, 2020

04:05PM EDT BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2020 earnings on Thursday, October 29 at 4:00 PM Eastern Time. GlobeNewswire Inc

Sep 17, 2020

01:51PM EDT BioTelemetry Option Alert: Oct 16 $50 Calls Sweep (24) near the Ask: 713 @ $0.451 vs 13 OI; Earnings 11/3 After Close [est] Ref=$42.98 Benzinga

Sep 11, 2020

09:38AM EDT Benzinga's Top Upgrades, Downgrades For September 11, 2020 Benzinga

06:34AM EDT Needham Initiates Coverage On BioTelemetry with Buy Rating, Announces Price Target of $52 Benzinga

Sep 2, 2020

10:21AM EDT Benzinga's Top Upgrades, Downgrades For September 2, 2020 Benzinga

06:12AM EDT Baird Initiates Coverage On BioTelemetry with Neutral Rating, Announces Price Target of $43 Benzinga

Jul 30, 2020

04:08PM EDT BioTelemetry Q2 EPS $0.35 Beats $0.16 Estimate, Sales $89.41M Miss $89.52M Estimate Benzinga

08:57AM EDT BioTelemetry Earlier Reported Sales Agent Deal With Boston Scientific For LUX-Dx Insertable Cardiac Monitor System, No Terms Disclosed Benzinga

07:00AM EDT BioTelemetry, Inc. Announces Sales Agent Agreement with Boston GlobeNewswire Inc

04:06AM EDT Earnings Scheduled For July 30, 2020 Benzinga

Jul 29, 2020

08:05AM EDT BioTelemetry, Inc. Acquires Remote Patient Monitoring Platform From Centene Subsidiary Benzinga

08:00AM EDT BioTelemetry, Inc. Acquires Remote Patient Monitoring Platform GlobeNewswire Inc

Jul 23, 2020

04:05PM EDT BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2020 earnings on Thursday, July 30 at 4:00 PM Eastern Time. GlobeNewswire Inc